PEEK 임플란트 시장 규모, 점유율, 동향 분석 리포트 : 용도별, 최종 용도별, 지역별, 부문별 예측(2024-2030년)

PEEK Implants Market Growth & Trends:

The global PEEK implants market size is anticipated to reach USD 1,520.4 million by 2030, registering a CAGR of 7.9% from 2024 to 2030, according to a new report by Grand View Research, Inc. Polyetheretherketone (PEEK) implants are expected to become popular in the years to come due to their advantages, including their resistance to corrosion, low weight, and biocompatibility. In addition, there is a greater need for PEEK implants due to the trend of minimally invasive surgical techniques.PEEK implants are biocompatible, meaning they are well-tolerated by the body, reducing the risk of adverse reactions or rejection. This property makes these implants suitable for a wide range of medical applications, including orthopedic, spinal, and dental surgeries.

Overall, the rising product demand reflects the ongoing trend toward innovative biomaterials that offer advantages in terms of biocompatibility, mechanical properties, radiolucency, and versatility. As healthcare providers and patients increasingly recognize the product benefits, their adoption is expected to continue to grow across a wide range of medical specialties. PEEK polymers are mostly used in spinal implants as their radiolucency enables medical personnel to see the bone fusion through the implant. One of the main areas of concentration for top PEEK manufacturers is the spine market. Increased number of new product launches and company collaborations/acquisitions have been fueling market growth.

For instance, in 2022, Kumovis GmbH, a developer of additive manufacturing solutions for customized healthcare applications located in Munich, Germany, was acquired by 3D Systems Corporation. Kumovis' solutions are based on their proprietary extrusion process, which was created especially for high-performance, medical-grade polymers like PEEK to be printed precisely. Furthermore, the growing acceptance of PEEK implants by medical professionals and regulatory agencies has been a major factor in the expansion of the market. North America was the dominant regional market in 2023 and accounted for the largest market share of 41.5% in the same year. The market's expansion in North America is ascribed to the existence of significant industry participants, an increase in orthopedic disorders, and government endorsements of novel products.

PEEK Implants Market Report Highlights:

• The market size was estimated at USD 906.3 million in 2023 and is expected to reach USD 964.9 Million in 2024
• The spinal implants application segment accounted for the largest revenue share of more than 36.9% in 2023
• This high share can be attributed to the increased cases of spinal disorders
• The hospitals & clinics end-use segment dominated the market with a share of around 64.1% in 2023
• Hospitals serve as primary healthcare providers, offering a wide range of medical services to individuals within the communities, which is the key factor responsible for segment growth

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Application
  • 1.2.2. End-use
  • 1.2.3. Regional scope
  • 1.2.4. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Parent market analysis (Model 2)
  • 1.7.4. Approach 2: Parent market analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market outlook
• 2.2. Segment outlook
  • 2.2.1. Application outlook
  • 2.2.2. End-use outlook
  • 2.2.3. Regional outlook
• 2.3. Competitive Insights

Chapter 3. PEEK Implants Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Rising adoption for spinal implants
    • 3.2.1.2. Rise in geriatric population
    • 3.2.1.3. Increasing Increasing demand for bio-inert implants
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Lack of skilled professionals
    • 3.2.2.2. High cost of surgeries
• 3.3. PEEK Implants Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. PEEK Implants Market: Application Estimates & Trend Analysis

• 4.1. PEEK Implants Market: Application Dashboard
• 4.2. PEEK Implants Market: Application Movement Analysis
• 4.3. PEEK Implants Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 4.4. Spinal Implants
  • 4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.5. Orthopedic Implants
  • 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.6. Dental Implants
  • 4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.7. Craniomaxillofacial Implants
  • 4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.8. Others
  • 4.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. PEEK Implants Market: End-use Estimates & Trend Analysis

• 5.1. PEEK Implants Market: End-use Dashboard
• 5.2. PEEK Implants Market: End-use Movement Analysis
• 5.3. PEEK Implants Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 5.4. Hospitals and Clinics
  • 5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 5.5. Ambulatory Surgical Centers
  • 5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 5.6. Others
  • 5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. PEEK Implants Market: Regional Estimates & Trend Analysis by Country, Application, & End-use

• 6.1. Regional Dashboard
• 6.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030
• 6.3. North America
  • 6.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.3.2. U.S.
    • 6.3.2.1. Key country dynamics
    • 6.3.2.2. Regulatory framework/ reimbursement structure
    • 6.3.2.3. Competitive scenario
    • 6.3.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.3.3. Canada
    • 6.3.3.1. Key country dynamics
    • 6.3.3.2. Regulatory framework/ reimbursement structure
    • 6.3.3.3. Competitive scenario
    • 6.3.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
• 6.4. Europe
  • 6.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.4.2. UK
    • 6.4.2.1. Key country dynamics
    • 6.4.2.2. Regulatory framework/ reimbursement structure
    • 6.4.2.3. Competitive scenario
    • 6.4.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.3. Germany
    • 6.4.3.1. Key country dynamics
    • 6.4.3.2. Regulatory framework/ reimbursement structure
    • 6.4.3.3. Competitive scenario
    • 6.4.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.4. France
    • 6.4.4.1. Key country dynamics
    • 6.4.4.2. Regulatory framework/ reimbursement structure
    • 6.4.4.3. Competitive scenario
    • 6.4.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.5. Italy
    • 6.4.5.1. Key country dynamics
    • 6.4.5.2. Regulatory framework/ reimbursement structure
    • 6.4.5.3. Competitive scenario
    • 6.4.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.6. Spain
    • 6.4.6.1. Key country dynamics
    • 6.4.6.2. Regulatory framework/ reimbursement structure
    • 6.4.6.3. Competitive scenario
    • 6.4.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.7. Norway
    • 6.4.7.1. Key country dynamics
    • 6.4.7.2. Regulatory framework/ reimbursement structure
    • 6.4.7.3. Competitive scenario
    • 6.4.7.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.8. Sweden
    • 6.4.8.1. Key country dynamics
    • 6.4.8.2. Regulatory framework/ reimbursement structure
    • 6.4.8.3. Competitive scenario
    • 6.4.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.9. Denmark
    • 6.4.9.1. Key country dynamics
    • 6.4.9.2. Regulatory framework/ reimbursement structure
    • 6.4.9.3. Competitive scenario
    • 6.4.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 6.5. Asia Pacific
  • 6.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.5.2. Japan
    • 6.5.2.1. Key country dynamics
    • 6.5.2.2. Regulatory framework/ reimbursement structure
    • 6.5.2.3. Competitive scenario
    • 6.5.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.3. China
    • 6.5.3.1. Key country dynamics
    • 6.5.3.2. Regulatory framework/ reimbursement structure
    • 6.5.3.3. Competitive scenario
    • 6.5.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.4. India
    • 6.5.4.1. Key country dynamics
    • 6.5.4.2. Regulatory framework/ reimbursement structure
    • 6.5.4.3. Competitive scenario
    • 6.5.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.5. Australia
    • 6.5.5.1. Key country dynamics
    • 6.5.5.2. Regulatory framework/ reimbursement structure
    • 6.5.5.3. Competitive scenario
    • 6.5.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.6. South Korea
    • 6.5.6.1. Key country dynamics
    • 6.5.6.2. Regulatory framework/ reimbursement structure
    • 6.5.6.3. Competitive scenario
    • 6.5.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.7. Thailand
    • 6.5.7.1. Key country dynamics
    • 6.5.7.2. Regulatory framework/ reimbursement structure
    • 6.5.7.3. Competitive scenario
    • 6.5.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 6.6. Latin America
  • 6.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.6.2. Brazil
    • 6.6.2.1. Key country dynamics
    • 6.6.2.2. Regulatory framework/ reimbursement structure
    • 6.6.2.3. Competitive scenario
    • 6.6.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.3. Mexico
    • 6.6.3.1. Key country dynamics
    • 6.6.3.2. Regulatory framework/ reimbursement structure
    • 6.6.3.3. Competitive scenario
    • 6.6.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.4. Argentina
    • 6.6.4.1. Key country dynamics
    • 6.6.4.2. Regulatory framework/ reimbursement structure
    • 6.6.4.3. Competitive scenario
    • 6.6.4.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 6.7. MEA
  • 6.7.1. South Africa
    • 6.7.1.1. Key country dynamics
    • 6.7.1.2. Regulatory framework/ reimbursement structure
    • 6.7.1.3. Competitive scenario
    • 6.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7.2. Saudi Arabia
    • 6.7.2.1. Key country dynamics
    • 6.7.2.2. Regulatory framework/ reimbursement structure
    • 6.7.2.3. Competitive scenario
    • 6.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7.3. UAE
    • 6.7.3.1. Key country dynamics
    • 6.7.3.2. Regulatory framework/ reimbursement structure
    • 6.7.3.3. Competitive scenario
    • 6.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7.4. Kuwait
    • 6.7.4.1. Key country dynamics
    • 6.7.4.2. Regulatory framework/ reimbursement structure
    • 6.7.4.3. Competitive scenario
    • 6.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Market Participants
• 7.2. Company/Competition Categorization
• 7.3. Vendor Landscape
  • 7.3.1. List of key distributors and channel partners
  • 7.3.2. Key customers
  • 7.3.3. Key company market share analysis, 2023
  • 7.3.4. Invibio
    • 7.3.4.1. Company overview
    • 7.3.4.2. Financial performance
    • 7.3.4.3. Product benchmarking
    • 7.3.4.4. Strategic initiatives
  • 7.3.5. Johnson & Johnson MedTech
    • 7.3.5.1. Company overview
    • 7.3.5.2. Financial performance
    • 7.3.5.3. Product benchmarking
    • 7.3.5.4. Strategic initiatives
  • 7.3.6. Evonik
    • 7.3.6.1. Company overview
    • 7.3.6.2. Financial performance
    • 7.3.6.3. Product benchmarking
    • 7.3.6.4. Strategic initiatives
  • 7.3.7. Solvay
    • 7.3.7.1. Company overview
    • 7.3.7.2. Financial performance
    • 7.3.7.3. Product benchmarking
    • 7.3.7.4. Strategic initiatives
  • 7.3.8. In2Bones Global, Inc
    • 7.3.8.1. Company overview
    • 7.3.8.2. Financial performance
    • 7.3.8.3. Product benchmarking
    • 7.3.8.4. Strategic initiatives
  • 7.3.9. HAPPE Spine
    • 7.3.9.1. Company overview
    • 7.3.9.2. Financial performance
    • 7.3.9.3. Product benchmarking
    • 7.3.9.4. Strategic initiatives
  • 7.3.10. NuVasive, Inc.
    • 7.3.10.1. Company overview
    • 7.3.10.2. Financial performance
    • 7.3.10.3. Product benchmarking
    • 7.3.10.4. Strategic initiatives
  • 7.3.11. Dental Technology Services
    • 7.3.11.1. Company overview
    • 7.3.11.2. Financial performance
    • 7.3.11.3. Product benchmarking
    • 7.3.11.4. Strategic initiatives
  • 7.3.12. 3D Systems, Inc.
    • 7.3.12.1. Company overview
    • 7.3.12.2. Financial performance
    • 7.3.12.3. Product benchmarking
    • 7.3.12.4. Strategic initiatives
  • 7.3.13. INNOVASIS
    • 7.3.13.1. Company overview
    • 7.3.13.2. Financial performance
    • 7.3.13.3. Product benchmarking
    • 7.3.13.4. Strategic initiatives
  • 7.3.14. SINTX Technologies, Inc.
    • 7.3.14.1. Company overview
    • 7.3.14.2. Financial performance
    • 7.3.14.3. Product benchmarking
    • 7.3.14.4. Strategic initiatives
  • 7.3.15. Quick Implants NZ Limited.
    • 7.3.15.1. Company overview
    • 7.3.15.2. Financial performance
    • 7.3.15.3. Product benchmarking
    • 7.3.15.4. Strategic initiatives